BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stasiulewicz A, Znajdek K, Grudzień M, Pawiński T, Sulkowska AJI. A Guide to Targeting the Endocannabinoid System in Drug Design. Int J Mol Sci 2020;21:E2778. [PMID: 32316328 DOI: 10.3390/ijms21082778] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 15.0] [Reference Citation Analysis]
Number Citing Articles
1 Tanaka K, Amoako AA, Mortlock S, Rogers PAW, Holdsworth-carson SJ, Donoghue JF, Teh WT, Montgomery GW, Mckinnon B. Gene expression of the endocannabinoid system in endometrium through menstrual cycle. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-13488-4] [Reference Citation Analysis]
2 Navarrete C, Garcia-Martin A, DeMesa J, Muñoz E. Cannabinoids in Metabolic Syndrome and Cardiac Fibrosis. Curr Hypertens Rep 2020;22:98. [PMID: 33089434 DOI: 10.1007/s11906-020-01112-7] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Morris G, Walder K, Berk M, Carvalho AF, Marx W, Bortolasci CC, Yung AR, Puri BK, Maes M. Intertwined associations between oxidative and nitrosative stress and endocannabinoid system pathways: Relevance for neuropsychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 2022;114:110481. [PMID: 34826557 DOI: 10.1016/j.pnpbp.2021.110481] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Hulland O, Oswald J. Cannabinoids and Pain: The Highs and Lows. Rheum Dis Clin North Am 2021;47:265-75. [PMID: 33781494 DOI: 10.1016/j.rdc.2020.12.005] [Reference Citation Analysis]
5 Coronado-Álvarez A, Romero-Cordero K, Macías-Triana L, Tatum-Kuri A, Vera-Barrón A, Budde H, Machado S, Yamamoto T, Imperatori C, Murillo-Rodríguez E. The synthetic CB1 cannabinoid receptor selective agonists: Putative medical uses and their legalization. Prog Neuropsychopharmacol Biol Psychiatry 2021;110:110301. [PMID: 33741446 DOI: 10.1016/j.pnpbp.2021.110301] [Reference Citation Analysis]
6 Seillier A. The endocannabinoid system as a therapeutic target for schizophrenia: Failures and potentials. Neurosci Lett 2021;759:136064. [PMID: 34146641 DOI: 10.1016/j.neulet.2021.136064] [Reference Citation Analysis]
7 Gurm H, Hirota JA, Raha S. Cannabinoid Signalling in Immune-Reproductive Crosstalk during Human Pregnancy. Biomedicines 2021;9:267. [PMID: 33800053 DOI: 10.3390/biomedicines9030267] [Reference Citation Analysis]
8 Nagoor Meeran MF, Javed H, Sharma C, Goyal SN, Kumar S, Jha NK, Ojha S. Can Echinacea be a potential candidate to target immunity, inflammation, and infection - The trinity of coronavirus disease 2019. Heliyon 2021;7:e05990. [PMID: 33585706 DOI: 10.1016/j.heliyon.2021.e05990] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Sugawara K, Zákány N, Tiede S, Purba T, Harries M, Tsuruta D, Bíró T, Paus R. Human epithelial stem cell survival within their niche requires "tonic" cannabinoid receptor 1-signalling-Lessons from the hair follicle. Exp Dermatol 2021;30:479-93. [PMID: 33523535 DOI: 10.1111/exd.14294] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Kalinkovich A, Livshits G. Biased and allosteric modulation of bone cell-expressing G protein-coupled receptors as a novel approach to osteoporosis therapy. Pharmacol Res 2021;171:105794. [PMID: 34329703 DOI: 10.1016/j.phrs.2021.105794] [Reference Citation Analysis]
11 Campos RMP, Aguiar AFL, Paes-colli Y, Trindade PMP, Ferreira BK, de Melo Reis RA, Sampaio LS. Cannabinoid Therapeutics in Chronic Neuropathic Pain: From Animal Research to Human Treatment. Front Physiol 2021;12:785176. [DOI: 10.3389/fphys.2021.785176] [Reference Citation Analysis]
12 MacDonald IJ, Chen YH. The Endocannabinoid System Contributes to Electroacupuncture Analgesia. Front Neurosci 2020;14:594219. [PMID: 33679287 DOI: 10.3389/fnins.2020.594219] [Reference Citation Analysis]
13 Haddad M. The Impact of CB1 Receptor on Inflammation in Skeletal Muscle Cells. J Inflamm Res 2021;14:3959-67. [PMID: 34421307 DOI: 10.2147/JIR.S322247] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Patel J, Maddukuri S, Li Y, Bax C, Werth VP. Highly Multiplexed Mass Cytometry Identifies the Immunophenotype in the Skin of Dermatomyositis. J Invest Dermatol 2021;141:2151-60. [PMID: 33766508 DOI: 10.1016/j.jid.2021.02.748] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Hou L, Rong J, Haider A, Ogasawara D, Varlow C, Schafroth MA, Mu L, Gan J, Xu H, Fowler CJ, Zhang MR, Vasdev N, Ametamey S, Cravatt BF, Wang L, Liang SH. Positron Emission Tomography Imaging of the Endocannabinoid System: Opportunities and Challenges in Radiotracer Development. J Med Chem 2021;64:123-49. [PMID: 33379862 DOI: 10.1021/acs.jmedchem.0c01459] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Tian S, Yan S, Meng Z, Huang S, Sun W, Jia M, Teng M, Zhou Z, Zhu W. New insights into bisphenols induced obesity in zebrafish (Danio rerio): Activation of cannabinoid receptor CB1. Journal of Hazardous Materials 2021;418:126100. [DOI: 10.1016/j.jhazmat.2021.126100] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
17 Önay Ö, Köse S, Süslü N, Korkusuz P, Nemutlu E, Aydın C, Hoşal Ş. Human laryngeal squamous cell carcinoma cell line release of endogenous anandamide and 2-arachidonoylglycerol, and their antiproliferative effect via exogenous supplementation: an in vitro study. Cell Tissue Bank 2021. [PMID: 33797678 DOI: 10.1007/s10561-021-09917-9] [Reference Citation Analysis]
18 Sihag J, Di Marzo V. (Wh)olistic (E)ndocannabinoidome-Microbiome-Axis Modulation through (N)utrition (WHEN) to Curb Obesity and Related Disorders. Lipids Health Dis 2022;21:9. [PMID: 35027074 DOI: 10.1186/s12944-021-01609-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
19 Jha NK, Sharma C, Meeran MFN, Jha SK, Dwivedi VD, Gupta PK, Dey A, Kesari KK, Ojha S. Cannabinoid Type-2 Receptor Agonist, JWH133 May Be a Possible Candidate for Targeting Infection, Inflammation, and Immunity in COVID-19. Immuno 2021;1:285-304. [DOI: 10.3390/immuno1030020] [Reference Citation Analysis]
20 Jenkins BW, Khokhar JY. Cannabis Use and Mental Illness: Understanding Circuit Dysfunction Through Preclinical Models. Front Psychiatry 2021;12:597725. [PMID: 33613338 DOI: 10.3389/fpsyt.2021.597725] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Arena C, Gado F, Di Cesare Mannelli L, Cervetto C, Carpi S, Reynoso-moreno I, Polini B, Vallini E, Chicca S, Lucarini E, Bertini S, D’andrea F, Digiacomo M, Poli G, Tuccinardi T, Macchia M, Gertsch J, Marcoli M, Nieri P, Ghelardini C, Chicca A, Manera C. The endocannabinoid system dual-target ligand N-cycloheptyl-1,2-dihydro-5-bromo-1-(4-fluorobenzyl)-6-methyl-2-oxo-pyridine-3-carboxamide improves disease severity in a mouse model of multiple sclerosis. European Journal of Medicinal Chemistry 2020;208:112858. [DOI: 10.1016/j.ejmech.2020.112858] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
22 Aderibigbe AO, Pandey P, Doerksen RJ. Negative allosteric modulators of cannabinoid receptor 1: Ternary complexes including CB1, orthosteric CP55940 and allosteric ORG27569. J Biomol Struct Dyn 2021;:1-19. [PMID: 33480332 DOI: 10.1080/07391102.2021.1873187] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Paes-colli Y, Aguiar AFL, Isaac AR, Ferreira BK, Campos RMP, Trindade PMP, de Melo Reis RA, Sampaio LS. Phytocannabinoids and Cannabis-Based Products as Alternative Pharmacotherapy in Neurodegenerative Diseases: From Hypothesis to Clinical Practice. Front Cell Neurosci 2022;16:917164. [DOI: 10.3389/fncel.2022.917164] [Reference Citation Analysis]
24 Melinyshyn AN, Amoozegar F. Cannabinoid Use in a Tertiary Headache Clinic: A Cross-Sectional Survey. Can J Neurol Sci 2021;:1-10. [PMID: 34511153 DOI: 10.1017/cjn.2021.215] [Reference Citation Analysis]
25 Hryhorowicz S, Kaczmarek-Ryś M, Zielińska A, Scott RJ, Słomski R, Pławski A. Endocannabinoid System as a Promising Therapeutic Target in Inflammatory Bowel Disease - A Systematic Review. Front Immunol 2021;12:790803. [PMID: 35003109 DOI: 10.3389/fimmu.2021.790803] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
26 Cong J, Lu K, Zou W, Li Z, Guo Z, Tong X, Zheng J, Zhu J, Li S, Zhang W, Guo Y, Gao TM, Chen R. Astroglial CB1 Cannabinoid Receptors Mediate CP 55,940-Induced Conditioned Place Aversion Through Cyclooxygenase-2 Signaling in Mice. Front Cell Neurosci 2021;15:772549. [PMID: 34887729 DOI: 10.3389/fncel.2021.772549] [Reference Citation Analysis]
27 Nagoor Meeran MF, Sharma C, Goyal SN, Kumar S, Ojha S. CB2 receptor-selective agonists as candidates for targeting infection, inflammation, and immunity in SARS-CoV-2 infections. Drug Dev Res 2021;82:7-11. [PMID: 33190277 DOI: 10.1002/ddr.21752] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
28 Tito PAL, Bernardino TCS, Bellozi PMQ, da Silva MCM, de Miranda AS, Vieira ÉLM, Moreira FA, Palotás A, de Oliveira ACP, Reis HJ. Cannabidiol prevents lipopolysaccharide-induced sickness behavior and alters cytokine and neurotrophic factor levels in the brain. Pharmacol Rep 2021;73:1680-93. [PMID: 34218397 DOI: 10.1007/s43440-021-00301-8] [Reference Citation Analysis]
29 Moreno E, Cavic M, Canela EI. Functional Fine-Tuning of Metabolic Pathways by the Endocannabinoid System-Implications for Health and Disease. Int J Mol Sci 2021;22:3661. [PMID: 33915889 DOI: 10.3390/ijms22073661] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
30 Rahaman O, Ganguly D. Endocannabinoids in immune regulation and immunopathologies. Immunology 2021. [PMID: 34053085 DOI: 10.1111/imm.13378] [Reference Citation Analysis]
31 Ahmed M, Boileau I, Le Foll B, Carvalho AF, Kloiber S. The endocannabinoid system in social anxiety disorder: from pathophysiology to novel therapeutics. Braz J Psychiatry 2021:S1516-44462021005023202. [PMID: 34468550 DOI: 10.1590/1516-4446-2021-1926] [Reference Citation Analysis]
32 Suriano F, Manca C, Flamand N, Depommier C, Van Hul M, Delzenne NM, Silvestri C, Cani PD, Di Marzo V. Exploring the endocannabinoidome in genetically obese (ob/ob) and diabetic (db/db) mice: Links with inflammation and gut microbiota. Biochim Biophys Acta Mol Cell Biol Lipids 2022;1867:159056. [PMID: 34606993 DOI: 10.1016/j.bbalip.2021.159056] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 El-atawneh S, Goldblum A. Candidate Therapeutics by Screening for Multitargeting Ligands: Combining the CB2 Receptor With CB1, PPARγ and 5-HT4 Receptors. Front Pharmacol 2022;13:812745. [DOI: 10.3389/fphar.2022.812745] [Reference Citation Analysis]
34 Kaminski NE, Kaplan BLF. Immunomodulation by cannabinoids: Current uses, mechanisms, and identification of data gaps to be addressed for additional therapeutic application. Adv Pharmacol 2021;91:1-59. [PMID: 34099105 DOI: 10.1016/bs.apha.2021.01.001] [Reference Citation Analysis]
35 Jakowiecki J, Abel R, Orzeł U, Pasznik P, Preissner R, Filipek S. Allosteric Modulation of the CB1 Cannabinoid Receptor by Cannabidiol-A Molecular Modeling Study of the N-Terminal Domain and the Allosteric-Orthosteric Coupling. Molecules 2021;26:2456. [PMID: 33922473 DOI: 10.3390/molecules26092456] [Reference Citation Analysis]
36 Ryan M. Cannabidiol in epilepsy: The indications and beyond. Ment Health Clin 2020;10:317-25. [PMID: 33224689 DOI: 10.9740/mhc.2020.11.317] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
37 Polini B, Cervetto C, Carpi S, Pelassa S, Gado F, Ferrisi R, Bertini S, Nieri P, Marcoli M, Manera C. Positive Allosteric Modulation of CB1 and CB2 Cannabinoid Receptors Enhances the Neuroprotective Activity of a Dual CB1R/CB2R Orthosteric Agonist. Life (Basel) 2020;10:E333. [PMID: 33302569 DOI: 10.3390/life10120333] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
38 Klawitter J, Sempio C, Jackson MJ, Smith PH, Hopp K, Chonchol M, Gitomer BY, Christians U, Klawitter J. Endocannabinoid System in Polycystic Kidney Disease. Am J Nephrol 2022;53:264-72. [PMID: 35263737 DOI: 10.1159/000522113] [Reference Citation Analysis]
39 Kuhathasan N, Minuzzi L, MacKillop J, Frey BN. The Use of Cannabinoids for Insomnia in Daily Life: Naturalistic Study. J Med Internet Res 2021;23:e25730. [PMID: 34704957 DOI: 10.2196/25730] [Reference Citation Analysis]